SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-23-000003
Filing Date
2023-01-05
Accepted
2023-01-05 16:31:32
Documents
15
Period of Report
2023-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20230105.htm   iXBRL 8-K 34332
2 EX-99.1 pcrx-december2022revenuepr.htm EX-99.1 35429
7 PACIRA BIOSCIENCES LOGO pacirabiosciencesa01.jpg GRAPHIC 27796
  Complete submission text file 0001396814-23-000003.txt   287399

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20230105.xsd EX-101.SCH 2163
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20230105_def.xml EX-101.DEF 14956
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20230105_lab.xml EX-101.LAB 29116
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20230105_pre.xml EX-101.PRE 15553
9 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20230105_htm.xml XML 12014
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 23511804
SIC: 2834 Pharmaceutical Preparations